Metformin alleviates glucolipotoxicity-induced pancreatic β cell ferroptosis through regulation of the GPX4/ACSL4 axis-Reference-Cited by-同舟云学术

Metformin alleviates glucolipotoxicity-induced pancreatic β cell ferroptosis through regulation of the GPX4/ACSL4 axis

Published:2023-10 Issue: Volume:956 Page:175967
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Sun Yue,Guo Li-qun,Wang De-guo,Xing Yu-jie,Bai Ya-ping,Zhang Teng,Wang Wen,Zhou Si-min,Yao Xin-ming,Cheng Jin-han,Chang Wei-wei,Lv Kun,Li Chun-xiao,Kong Xiang^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. Glucotoxicity promotes aberrant activation and mislocalization of Ras-related C3 botulinum toxin substrate 1 [Rac1] and metabolic dysfunction in pancreatic islet β-cells: reversal of such metabolic defects by metformin;Baidwan;Apoptosis,2017

2. Epidemiological associations between iron and cardiovascular disease and diabetes;Basuli;Front. Pharmacol.,2014

3. Importance of NADPH oxidase-mediated redox signaling in the detrimental effect of CRP on pancreatic insulin secretion;Chan;Free Radic. Biol. Med.,2017

4. Ferroptosis: machinery and regulation;Chen;Autophagy,2021

5. Characteristics and biomarkers of ferroptosis;Chen;Front. Cell Dev. Biol.,2021

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of unique indole-benzosulfonamide oleanolic acid derivatives as potent antibacterial agents against MRSA;European Journal of Medicinal Chemistry;2024-10

2. Multi-responsive cascade enzyme-like catalytic nanoassembly for ferroptosis amplification and nanozyme-assisted mild photothermal therapy;Acta Biomaterialia;2024-08

3. Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo;Biochemical Pharmacology;2024-06

4. The significance of glutaredoxins for diabetes mellitus and its complications;Redox Biology;2024-05

5. N-p-coumaroyloctopamine ameliorates hepatic glucose metabolism and oxidative stress involved in a PI3K/AKT/GSK3β pathway;Frontiers in Pharmacology;2024-04-25